 Hypoglycemic Agents
"Hypoglycemic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances which lower blood glucose levels.
| Descriptor ID |
D007004
|
| MeSH Number(s) |
D27.505.696.422
|
| Concept/Terms |
Hypoglycemic Agents- Hypoglycemic Agents
- Agents, Hypoglycemic
- Hypoglycemics
- Hypoglycemic Drugs
- Drugs, Hypoglycemic
- Antihyperglycemic Agents
- Agents, Antihyperglycemic
- Antihyperglycemics
Hypoglycemic Effect- Hypoglycemic Effect
- Effect, Hypoglycemic
- Hypoglycemic Effects
- Effects, Hypoglycemic
Antidiabetics- Antidiabetics
- Antidiabetic Drugs
- Drugs, Antidiabetic
- Antidiabetic Agents
- Agents, Antidiabetic
|
Below are MeSH descriptors whose meaning is more general than "Hypoglycemic Agents".
Below are MeSH descriptors whose meaning is more specific than "Hypoglycemic Agents".
This graph shows the total number of publications written about "Hypoglycemic Agents" by people in this website by year, and whether "Hypoglycemic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 1 | 0 | 1 | | 1995 | 1 | 1 | 2 | | 1996 | 1 | 0 | 1 | | 1997 | 3 | 4 | 7 | | 1998 | 2 | 3 | 5 | | 1999 | 0 | 2 | 2 | | 2000 | 4 | 3 | 7 | | 2001 | 1 | 3 | 4 | | 2002 | 4 | 2 | 6 | | 2003 | 4 | 2 | 6 | | 2004 | 5 | 4 | 9 | | 2005 | 5 | 3 | 8 | | 2006 | 7 | 4 | 11 | | 2007 | 3 | 6 | 9 | | 2008 | 6 | 3 | 9 | | 2009 | 4 | 6 | 10 | | 2010 | 6 | 6 | 12 | | 2011 | 4 | 5 | 9 | | 2012 | 3 | 4 | 7 | | 2013 | 10 | 8 | 18 | | 2014 | 11 | 8 | 19 | | 2015 | 13 | 5 | 18 | | 2016 | 9 | 7 | 16 | | 2017 | 12 | 6 | 18 | | 2018 | 6 | 11 | 17 | | 2019 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Hypoglycemic Agents" by people in Profiles.
-
Mohiuddin MS, Himeno T, Inoue R, Miura-Yura E, Yamada Y, Nakai-Shimoda H, Asano S, Kato M, Motegi M, Kondo M, Seino Y, Tsunekawa S, Kato Y, Suzuki A, Naruse K, Kato K, Nakamura J, Kamiya H. Glucagon-Like Peptide-1 Receptor Agonist Protects Dorsal Root Ganglion Neurons against Oxidative Insult. J Diabetes Res. 2019; 2019:9426014.
-
Basu A, Sohn MW, Bartle B, Chan KCG, Cooper JM, Huang E. Development and Validation of the Real-World Progression in Diabetes (RAPIDS) Model. Med Decis Making. 2019 02; 39(2):137-151.
-
Tung EL, Davis AM, Laiteerapong N. Guidelines on Glycemic Targets for Persons With Type 2 Diabetes-Reply. JAMA. 2018 11 13; 320(18):1937-1938.
-
Chen J, Sun J, Prinz RA, Li Y, Xu X. Gingerenone A Sensitizes the Insulin Receptor and Increases Glucose Uptake by Inhibiting the Activity of p70 S6 Kinase. Mol Nutr Food Res. 2018 12; 62(23):e1800709.
-
White WB, Jalil F, Cushman WC, Bakris GL, Bergenstal R, Heller SR, Liu Y, Mehta C, Zannad F, Cannon CP. Average Clinician-Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial. J Am Heart Assoc. 2018 10 16; 7(20):e009114.
-
Turksoy K, Hajizadeh I, Hobbs N, Kilkus J, Littlejohn E, Samadi S, Feng J, Sevil M, Lazaro C, Ritthaler J, Hibner B, Devine N, Quinn L, Cinar A. Multivariable Artificial Pancreas for Various Exercise Types and Intensities. Diabetes Technol Ther. 2018 10; 20(10):662-671.
-
Twu J, Patel N, Wolf JM, Conti Mica M. Impact of Variation of Corticosteroid Dose, Injection Site, and Multiple Injections on Blood Glucose Measurement in Diabetic Patients. J Hand Surg Am. 2018 08; 43(8):738-744.
-
Myerson R, Lu T, Tonnu-Mihara I, Huang ES. Medicaid Eligibility Expansions May Address Gaps In Access To Diabetes Medications. Health Aff (Millwood). 2018 08; 37(8):1200-1207.
-
Hajizadeh I, Rashid M, Turksoy K, Samadi S, Feng J, Sevil M, Hobbs N, Lazaro C, Maloney Z, Littlejohn E, Cinar A. Incorporating Unannounced Meals and Exercise in Adaptive Learning of Personalized Models for Multivariable Artificial Pancreas Systems. J Diabetes Sci Technol. 2018 09; 12(5):953-966.
-
Lipska KJ, Parker MM, Moffet HH, Huang ES, Karter AJ. Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes. JAMA. 2018 07 03; 320(1):53-62.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|